Keeratikarn Boonyawan
Papers
1
Total Citations
4
H-Index
1
About
Dr. Keeratikarn Boonyawan is a distinguished researcher in the field of radiation oncology, with a specialized focus on stereotactic radiotherapy for complex cranial and spinal conditions. Their most cited work, a 2023 study on long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients, has garnered 4 citations, establishing a foundation for understanding the efficacy and safety of this precise treatment modality in a challenging patient population. This research contributes critical insights into tumor control, hearing preservation, and quality-of-life outcomes, addressing a significant unmet need in neuro-oncology. Dr. Boonyawan’s major contributions lie in advancing personalized radiotherapy approaches for rare genetic disorders, particularly by demonstrating the feasibility of managing bilateral tumors while minimizing neurological deficits. Their work underscores the importance of long-term follow-up in assessing treatment durability and toxicity, offering a benchmark for future clinical trials. By bridging the gap between technological innovation and patient-centered care, Dr. Boonyawan has made a notable impact on the management of neurofibromatosis type 2, providing a valuable reference for clinicians and researchers striving to optimize outcomes in this rare disease.
Research Focus
Key Achievements
Top Papers
- 1